A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer
J.A. Roberts, A. P. Kudelka, D. R. Spriggs, F. Muggia, J. Lurain, W. Grove, C. Kowal
International Journal of Gynecologic Cancer Jul 1996, 6 (4) 257-260; DOI: 10.1136/ijgc-00009577-199607000-00002
